IMMUNOGLOBULIN G1, ANTI-(HUMAN MUCIN MUC1) (HUMAN-MOUSE MONOCLONAL HPAM4 HEAVY CHAIN), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL HPAM4 .KAPPA.-CHAIN, DIMER
Metastatic Pancreatic Adenocarcinoma
Gilead Sciencesmonoclonal_antibodyPhase 1Dormant
CC
41/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 28/ 100
- Competitive Position
- 81/ 100
Competitive context
32 Active assets in the Metastatic Pancreatic Adenocarcinoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Olaparib Lantern Pharma Inc. | Phase 3 | BB |
Epirubicin Minia University | Phase 3 | BB |
Pembrolizumab Mayo Clinic | Phase 2 | BB |
Irinotecan Sucrosofate SWOG Cancer Research Network | Phase 3 | BB |
Irinotecan National Cancer Institute (NCI) | Phase 3 | BB |
View all 50 →
Same molecule, other indications
IMMUNOGLOBULIN G1, ANTI-(HUMAN MUCIN MUC1) (HUMAN-MOUSE MONOCLONAL HPAM4 HEAVY CHAIN), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL HPAM4 .KAPPA.-CHAIN, DIMER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →